In a recent collaboration between HOPA and Eisai, studies show that 83 percent of patients receiving chemotherapy may be unnecessarily suffering from Chemotherapy-Induced Nausea and Vomiting (CINV).

HOPA and Eisai have joined together to raise awareness about the impact of CINV to encourage and improve conversations about this treatment-related side effect between patients and their pharmacists.

Check out HOPA president, Scott Soefje, as he discusses the impact that CINV has on patients, and the importance of communication between patients and their pharmacists.


CINV Infographic Survey InfographicPress Release


alt  Interviews   Mary Van Dyke Bio Scott Soefje Bio